- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02111525
Fluid Status of Outpatients With Dyspnea (FLOOD)
October 13, 2015 updated by: Intersection Medical, Inc.
The purpose of this study is to determine the distribution of lung fluid status as reported by the IMED-4 system in patients presenting to the emergency department or urgent care facility with shortness of breath.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
156
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State University Hospital
-
-
Tennessee
-
Nashville, Tennessee, United States, 37235
- Vanderbilt University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients who present with shortness of breath to an emergency department or urgent care facility are possible candidates for the study and shall be screened for suitability based on the inclusion and exclusion criteria.
Description
INCLUSION CRITERIA
- Shortness of breath as the most prominent presenting symptom
- Age greater ≥ 45
- Willingness, ability, and commitment to participate in the study
EXCLUSION CRITERIA
- Patients with any active implantable medical device
- Patients who are pregnant or lactating
- Patients who have tattoos and or non-intact skin directly under the electrode position
- Patients who have had past allergic reactions to medical grade adhesives
- Patients that are dialysis dependent
- Patients who have had a lung lobectomy
- Patients in whom the shortness of breath presentation is due to obvious non HF cause such as acute chest trauma
- Patients who have received nitrates (sub-lingual, topical or IV), diuretics or vasopressors ≥ 1 hour prior to IMED-4 Recording
- Patients who decline to have their backs photographed with the IMED-4 device in position
- Patients who are receiving invasive or non-invasive positive airway pressure (PAP) ventilation prior to or following presentation to the ED (Self presentation or admission via EMS).
- Severe co-morbidity or poor general physical/mental health that, in the opinion of the Investigator, will not allow the subject to be a good study candidate (i.e. other disease processes, mental capacity, substance abuse, incarceration, shortened life expectancy, etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lung Fluid Status
Time Frame: Up to 1 year
|
The IMED 4 is a new device designed to measure the lung fluid status by assessing how wet or dry the lungs are
|
Up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (ACTUAL)
September 1, 2015
Study Completion (ACTUAL)
October 1, 2015
Study Registration Dates
First Submitted
April 8, 2014
First Submitted That Met QC Criteria
April 10, 2014
First Posted (ESTIMATE)
April 11, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
October 14, 2015
Last Update Submitted That Met QC Criteria
October 13, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CP-000030
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Congestion
-
Catharina Ziekenhuis EindhovenCompletedPulmonary CongestionNetherlands
-
University Hospital, GrenobleUnknownAcute Heart Failure | Pulmonary Congestion
-
Third Wave TherapeuticsCompleted
-
McNeil ABCompletedNasal CongestionRussian Federation
-
GlaxoSmithKlineCompletedCongestion, NasalUnited States
-
GlaxoSmithKlineCompletedNasal CongestionUnited Kingdom
-
University of ChicagoSanofiCompletedMucosal CongestionUnited States
-
Johnson & Johnson Consumer and Personal Products...Completed
-
GlaxoSmithKlineCompletedCongestion, NasalUnited States
-
Omega PharmaCompleted